XML 21 R7.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Operating Activities:      
Net income $ 76,598 $ 95,393 $ 70,119
Adjustments to reconcile net income to cash provided by operating activities:      
Depreciation and amortization 37,764 31,029 35,029
Deferred income taxes (8,843) (711) (11,103)
Gain on CRS settlement   (9,949)  
Revaluation of derivatives   (490) (1,039)
Debt extinguishment expenses     1,370
Stock compensation 9,186 6,018 4,652
Loss on sale of property and equipment 468 20 131
Loss from write-off of intangible assets   358  
Provision for doubtful accounts 108 (120) 24
Defined benefit pension plan expense 184 668 820
Gain from equity investment     (785)
Changes in operating assets and liabilities:      
Accounts receivable (17,971) (12,399) (16,902)
Inventory (5,933) (10,954) (8,367)
Prepaid expenses and other assets 9,106 (11,122) (5,871)
Accounts payable 4,419 8,049 6,956
Accrued liabilities 3,314 8,922 5,301
Net cash provided by operating activities 108,400 104,712 80,335
Investing Activities:      
Settlement of derivative financial instruments   (7,593)  
Investment in subsidiary, net of cash acquired (73,593) 107 (31,474)
Investment in development-stage entity (4,486)    
Purchases of property and equipment (66,316) (55,490) (38,887)
Proceeds from the sale of property and equipment 57 248 487
Net cash used in investing activities (144,338) (62,728) (69,874)
Financing Activities:      
Cash paid for financing costs (649)   (1,139)
Borrowing of Debt 115,000 15,000 91,592
Repayments of Debt (42,244) (5,053) (79,692)
Cash paid for the cancellation of restricted stock (1,196) (1,475) (1,113)
Excess tax benefit from equity awards 7,509 6,681 1,831
Proceeds from the exercise of Common Stock options 1,438 9,273 7,176
Net cash provided by financing activities 79,858 24,426 18,655
Foreign currency effect on cash and cash equivalents (11,212) (7,631) 1,699
Net increase in cash and cash equivalents 32,708 58,779 30,815
Cash and cash equivalents at beginning of period 144,479 85,700 54,885
Cash and cash equivalents at end of period 177,187 144,479 85,700
Supplemental disclosure of cash flow information:      
Cash paid for interest 3,029 2,826 2,558
Cash paid for taxes 21,608 32,376 21,756
Supplemental disclosure of non-cash transactions:      
Common Stock issued to directors and employees $ 4,589 $ 3,734 $ 2,706